IQX Limited FPO

IQX0.130
  • CHANGE
    0.00%
  • LAST
    0.13
  • VOLUME
    74800
  • LAST TRADE
    10-Aug-2021 2:48:27 PM

Announcements For IQX


Code Headline Release Date

IQX

Price Sensitive
40060 NSX Removal from Official List - Company Removed from Official List - Failure to pay Annual Listing Fee - 2022/2023 - Delisted 19th of September 2022
Company Removed from Official List - Failure to pay Annual Listing Fee - 2022/2023 - Delisted 19th of September 2022
19-Sep-2022 10:06:24 AM;20220919100624

IQX

Price Sensitive
40050 NSX Suspension from Official Quotation - Continued Suspensison - Failure to lodge Preliminary Final Report for 30 June 2022
Continued Suspensison - Failure to lodge Preliminary Final Report for 30 June 2022
14-Sep-2022 10:09:58 AM;20220914100958

IQX

Price Sensitive
40050 NSX Suspension from Official Quotation - Continued Suspension - Non-payment of Annual Listing Fee 2022-2023
Continued Suspension - Non-payment of Annual Listing Fee 2022-2023
15-Aug-2022 9:55:47 AM;20220815095547

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Execution Of Deed Of Company Arrangement
Execution Of Deed Of Company Arrangement
05-Aug-2022 4:41:30 PM;20220805164130

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Outcome Of Creditors' Meeting
Outcome Of Creditors' Meeting
01-Aug-2022 3:36:41 PM;20220801153641

IQX

Price Sensitive
40050 NSX Suspension from Official Quotation - Deferral Financial Reporting Obligations
Deferral Financial Reporting Obligations
17-May-2022 10:16:10 AM;20220517101610

IQX

Price Sensitive
40050 NSX Suspension from Official Quotation - Continued Suspension - Failure to lodge Half Yearly Financial Statements- 31 December 2021
Continued Suspension - Failure to lodge Half Yearly Financial Statements- 31 December 2021
17-Mar-2022 10:06:54 AM;20220317100654

IQX

Price Sensitive
40050 NSX Suspension from Official Quotation - The phone number for the VA has now been corrected
The phone number for the Voluntary Administrator was incorrect and nothing else has changed.
16-Mar-2022 8:09:09 AM;20220316080909

IQX

Price Sensitive
40050 NSX Suspension from Official Quotation - IQX Limited Seeks Voluntary Admin today to Restructure
IQX Limited seeks Voluntary Administration today to restructure
11-Mar-2022 8:31:40 AM;20220311083140

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Worldwide license for Harvard Uni’s eRapid Technology
Antisoma Therapeutics secures worldwide license for Harvard University’s eRapid technology for at-home diagnostic testing
07-Mar-2022 10:30:36 AM;20220307103036

IQX

40023 NSX Director's Declaration & Undertaking - Director's Declaration and Undertaking
Director's declaration and undertaking on behalf of Vincenzo Milazzo
15-Dec-2021 10:26:28 AM;20211215102628

IQX

40814 NSX Company Secretary Appointment/Resignation - Appointment/Resignation of Company Secretary
Appointment/Resignation of Company Secretary
13-Dec-2021 4:48:32 PM;20211213164832

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - FDA Breakthrough Devices Designation
FDA Breakthrough Devices Designation application to fast track rapid saliva glucose testing
13-Dec-2021 10:10:37 AM;20211213101037

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interest-Vincenzo Milazzo
Initial Director's Interest-Vincenzo Milazzo
25-Nov-2021 10:23:37 AM;20211125102337

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Director's Interest-John Stratilas
Final Director's Interest-John Stratilas
25-Nov-2021 10:23:33 AM;20211125102333

IQX

40810 NSX Director Appointment/Resignation - Director Resignation and Appointment
Appointment of Director Vincenzo Milazzo and Resignation of Director John Stratilas
25-Nov-2021 10:23:29 AM;20211125102329

IQX

40930 NSX Results of Meeting - IQX Results of AGM FY2021
IQX Results of AGM FY2021
19-Nov-2021 10:50:29 AM;20211119105029

IQX

40516 NSX Chairman's Address - IQX Chairman's Address
IQX Chairman's Address to Shareholders AGM: 19 November 2021
18-Nov-2021 4:50:14 PM;20211118165014

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Wyss Validation Study SARS-CoV-2
Wyss Validation Study SARS-CoV-2
11-Nov-2021 9:06:19 AM;20211111090619

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - OncoTEX Gold Compound Licensing
Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX
05-Nov-2021 9:06:17 AM;20211105090617

IQX

41999 NSX General Market Disclosure Other - Jobkeeper s323DB Notice
Jobkeeper s323DB Notice
02-Nov-2021 2:30:52 PM;20211102143052

IQX

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting & Proxy Form
Notice of Annual General Meeting & Proxy Form
20-Oct-2021 8:24:47 AM;20211020082447

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - LSBD Update on Biosensor FDA Pre-Submission
Filed a Pre-Submission package with the United States (US) Food and Drug Administration (FDA).
19-Oct-2021 9:28:59 AM;20211019092859

IQX

Price Sensitive
40510 NSX Annual Report - Annual Report 2021
Annual Report June 2021
09-Sep-2021 4:53:32 PM;20210909165332

IQX

40024 NSX Nominated Adviser's Declaration - Annual Nominated Adviser Statement - 2021-2022
Annual Nominated Adviser Statement - 2021-2022
23-Aug-2021 3:25:37 PM;20210823152537

IQX

Price Sensitive
40099 NSX Official List Other - Portfolio Company Awarded $6.3M Federal Govt Grant
GBS awarded $6.3 million Federal Government science grant to manufacture biosensor technology.
09-Jul-2021 9:27:15 AM;20210709092715

IQX

40814 NSX Company Secretary Appointment/Resignation - Appointment / Resignation of Company Secretary
Appointment / Resignation of Company Secretary
04-May-2021 9:09:42 AM;20210504090942

IQX

41999 NSX General Market Disclosure Other - Progress of clinical programs
Progress of clinical programs by its subsidiary companies; Life Science Biosensor Diagnostics Pty Ltd and OncoTex Inc.
29-Apr-2021 3:20:35 PM;20210429152035

IQX

Price Sensitive
40540 NSX Half Yearly Report - iQX Limited Half-yearly Report
iQx Limited Half-yearly Financial Report
09-Mar-2021 4:46:19 PM;20210309164619

IQX

40829 NSX Appointment/Resignation Other - iQX Change of Auditor
Change of Auditor
01-Feb-2021 11:24:00 AM;20210201112400

IQX

40930 NSX Results of Meeting - iQX Results of AGM
iQX Results of AGM
29-Jan-2021 3:23:08 PM;20210129152308

IQX

40516 NSX Chairman's Address - iQX Chairmans Address
Chairman's Address to Shareholders for AGM 29 January 2021
28-Jan-2021 4:48:32 PM;20210128164832

IQX

Price Sensitive
40081 NSX Response to Query - Response to Price Query
Response to Price Query
22-Jan-2021 10:30:28 AM;20210122103028

IQX

Price Sensitive
40080 NSX Query - Price Query
Price Query
22-Jan-2021 10:30:25 AM;20210122103025

IQX

40814 NSX Company Secretary Appointment/Resignation - iQX Limited Appointment/Resignation of CoSec
iQX Limited Appointment/Resignation of Company Secretary 12 January 2021
12-Jan-2021 2:59:39 PM;20210112145939

IQX

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting & Proxy Form
Notice of Annual General Meeting & Proxy Form
24-Dec-2020 11:30:49 AM;20201224113049

IQX

40031 NSX Trading Halt Status - Removal of Trading Halt
Removal of Trading Halt
02-Dec-2020 10:15:50 AM;20201202101550

IQX

Price Sensitive
40030 NSX Trading Halt - Request Trading Halt
Request Trading Halt Regarding License from Wyss Institute at Harvard University
01-Dec-2020 11:08:11 AM;20201201110811

IQX

40999 NSX Notice of Meeting Other - Postponement of Annual General Meeting
Postponement of Annual General Meeting
25-Nov-2020 12:28:54 PM;20201125122854

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Media Report
Media report in relation to Disrupt litigation
23-Nov-2020 4:06:33 PM;20201123160633

IQX

Price Sensitive
40510 NSX Annual Report - Annual Report to the Shareholders
Annual Report to the Shareholders
26-Oct-2020 8:07:07 AM;20201026080707

IQX

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting & Proxy Form
Notice of Annual General Meeting & Proxy Form
26-Oct-2020 8:06:58 AM;20201026080658

IQX

Price Sensitive
40510 NSX Annual Report - Annual Report 2020
Annual Report June 2020
11-Sep-2020 5:29:18 PM;20200911172918

IQX

41999 NSX General Market Disclosure Other - Completion of Share Split
Completion of Share Split
30-Jul-2020 2:52:17 PM;20200730145217

IQX

41999 NSX General Market Disclosure Other - Change in Auditor Entity
Change in Auditor Entity
22-Jul-2020 7:32:18 AM;20200722073218

IQX

40150 NSX Section 205G Notice Change in Director's Interests - Change in Direcror's Interests - P. Simpson
Change in Direcror's Interests - P. Simpson
20-Jul-2020 10:27:45 AM;20200720102745

IQX

40150 NSX Section 205G Notice Change in Director's Interests - Change in Direcror's Interests - J Stratilas
Change in Direcror's Interests - J Stratilas
20-Jul-2020 10:20:44 AM;20200720102044

IQX

40150 NSX Section 205G Notice Change in Director's Interests - Directors Change of Interest - G. Syrmalis
Directors Change of Interest - G. Syrmalis
20-Jul-2020 10:20:30 AM;20200720102030

IQX

Price Sensitive
40335 NSX Alteration to Issued Capital - Application for Quotation of Additional Securities From Share Split, Top 20 & Holding Analysis
Application for Quotation of Additional Securities From Share Split, Top 20 & Holding Analysis
20-Jul-2020 10:11:21 AM;20200720101121

IQX

40335 NSX Alteration to Issued Capital - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities for Directors Shares Approved at EGM and Employee Shares Issued under Employee Share Plan - Top 20 & Holding Analysis
16-Jul-2020 7:07:27 PM;20200716190727

IQX

Price Sensitive
40335 NSX Alteration to Issued Capital - Indicative Timetable for Proposed Share Split
Indicative Timetable for Proposed Share Split
15-Jul-2020 12:30:39 PM;20200715123039

IQX

40930 NSX Results of Meeting - Results of EGM
Results of Extraordinary General Meeting
14-Jul-2020 1:25:36 PM;20200714132536

IQX

40999 NSX Notice of Meeting Other - Change of Venue EGM
Change of venue of EGM on 14 July due to government measures
06-Jul-2020 9:00:58 AM;20200706090058

IQX

40920 NSX Notice of Extraordinary Meeting - Notice of EGM
Notice of Extraordinary General Meeting regarding proposed share split & other matters
10-Jun-2020 4:16:05 PM;20200610161605

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - COVID-19 Diagnostic Test With Harvard University
COVID-19 Diagnostic Test Collaboration with Wyss Institute for Biology Inspired Engineering, Harvard University
29-May-2020 11:12:51 AM;20200529111251

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - FDA Engagement Commences for Saliva Glucose Biosensor
Market announcement – Life Science Biosensor Diagnostics Pty Ltd (LSBD) commences FDA engagement for Saliva Glucose Biosensor Diagnostic Test.
05-May-2020 9:26:20 AM;20200505092620

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Director's Interests K Dimitriou
Final Director's Interests K Dimitriou
27-Mar-2020 10:26:21 AM;20200327102621

IQX

Price Sensitive
40811 NSX Chairman Appointment/Resignation - Chairman Appointment / Resignation
Chairman Appointment / Resignation
23-Mar-2020 12:11:32 PM;20200323121132

IQX

Price Sensitive
40540 NSX Half Yearly Report - IQX Half Yearly Report 31 December 2019
IQX Half Yearly Report 31 December 2019
16-Mar-2020 8:34:19 AM;20200316083419

IQX

40930 NSX Results of Meeting - Results of Annual General Meeting
Results of Annual General Meeting
26-Nov-2019 9:07:30 AM;20191126090730

IQX

41999 NSX General Market Disclosure Other - iQX Equity Crowd-Funding Platform
iQX Equity Crowd-Funding Platform Capital Labs launches new investment offer driving Australia’s next era of patient care
11-Nov-2019 9:43:52 AM;20191111094352

IQX

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting & Proxy Form
Notice of Annual General Meeting & Proxy Form
25-Oct-2019 3:52:20 PM;20191025155220

IQX

Price Sensitive
40510 NSX Annual Report - 30 June 2019
Annual Report 30th June 2019
01-Oct-2019 7:04:11 AM;20191001070411

IQX

41999 NSX General Market Disclosure Other - IQX acquires interest in new anticancer drug platform
IQX acquires interest in a new anticancer drug platform from University of Texas
18-Sep-2019 7:08:58 AM;20190918070858

IQX

Price Sensitive
40530 NSX Preliminary/Final Statement - 30 June 2019 Preliminary Financial Statements
30 June 2019 Preliminary Financial Statements
16-Sep-2019 9:35:13 AM;20190916093513

IQX

Price Sensitive
40081 NSX Response to Query - Response to Price Query
Response to Price Query
06-Sep-2019 10:31:12 AM;20190906103112

IQX

Price Sensitive
40080 NSX Query - Price Query
Price Query
06-Sep-2019 10:31:09 AM;20190906103109

IQX

41999 NSX General Market Disclosure Other - Change of Auditor
IQX Limited advises of a change of auditor from RSM Australia Partners to BDO East Coast Partnership
23-Jul-2019 8:49:28 AM;20190723084928

IQX

41999 NSX General Market Disclosure Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
01-May-2019 8:28:44 AM;20190501082844

IQX

Price Sensitive
40315 NSX Placement - Private Placement
Share Allotment & Cleansing Notice
26-Apr-2019 8:15:04 AM;20190426081504

IQX

Price Sensitive
40540 NSX Half Yearly Report - IQX Half Yearly Report
IQX Half Yearly Report to 31 December 2018
18-Mar-2019 6:02:31 AM;20190318060231

IQX

40315 NSX Placement - Application for Quotation of Additional Securities and amended Top 20 Shareholders List
Application for Quotation of Additional Securities and amended Top 20 Shareholders List
16-Jan-2019 6:20:38 PM;20190116182038

IQX

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities being ordinary shares issued.
16-Jan-2019 4:43:41 PM;20190116164341

IQX

Price Sensitive
40315 NSX Placement - Share Allotment
Share Allotment & Cleansing Notice
15-Jan-2019 3:05:18 PM;20190115150518

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - General Market Disclosure
GBSG qualified by US regulator to undertake capital raise and applies to list on Nasdaq Stock Exchange
28-Nov-2018 10:48:38 AM;20181128104838

IQX

40930 NSX Results of Meeting - Results of Meeting
Results of 2018 AGM
27-Nov-2018 9:12:04 AM;20181127091204

IQX

40516 NSX Chairman's Address - Chairman's Address
Chairman's Address
26-Nov-2018 9:33:55 AM;20181126093355

IQX

40910 NSX Notice of Annual General Meeting - Notice of 2018 AGM
Notice of 2018 AGM
26-Oct-2018 5:00:24 PM;20181026170024

IQX

41999 NSX General Market Disclosure Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
22-Oct-2018 3:53:19 PM;20181022155319

IQX

40315 NSX Placement - IQX - Private Placement
IQX - Private Placement
18-Oct-2018 9:15:51 AM;20181018091551

IQX

Price Sensitive
40510 NSX Annual Report - 2018 Annual Report
2018 Annual Report
30-Sep-2018 5:10:18 PM;20180930171018

IQX

Price Sensitive
40530 NSX Preliminary/Final Statement - 2018 Preliminary Final Results & Financial Statements
2018 Preliminary Final Results & Financial Statements
14-Sep-2018 7:02:19 AM;20180914070219

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Chinese Patent Granted for Biosensor Platform
Chinese Patent Granted for Biosensor Platform
02-Jul-2018 4:18:37 PM;20180702161837

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Update on Saliva Glucose Biosensor & BioSensX
Update on Saliva Glucose Biosensor & BioSensX Digital Point of Care Diagnostics
06-Jun-2018 3:00:41 PM;20180606150041

IQX

40399 NSX Issued Capital Other - Application for Quotation of New Securities
Application for Quotation of New Securities
29-Mar-2018 2:24:04 PM;20180329142404

IQX

40120 NSX Change in Substantial Shareholder - Change in Substantial Shareholder
Change in Substantial Shareholder
29-Mar-2018 1:58:45 PM;20180329135845

IQX

40120 NSX Change in Substantial Shareholder - Change in Substantial Shareholder
Change in Substantial Shareholder
29-Mar-2018 1:55:54 PM;20180329135554

IQX

40150 NSX Section 205G Notice Change in Director's Interests - Change of Director's Interests
Change of Director's Interests
29-Mar-2018 10:45:11 AM;20180329104511

IQX

Price Sensitive
40550 NSX Half Yearly Report Audit Review - Half Yearly Report
31 December 2017 Financial Statements
16-Mar-2018 2:14:08 PM;20180316141408

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Capital Labs Live
Capital Labs to list its first live investment offer to Australian retail investors
13-Mar-2018 9:09:54 AM;20180313090954

IQX

41999 NSX General Market Disclosure Other - Change of Address
Relocating to New Corporate Headquarters
01-Mar-2018 12:01:54 PM;20180301120154

IQX

40335 NSX Alteration to Issued Capital - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities being ordinary shares issued on the conversion of convertible notes
24-Jan-2018 5:47:31 PM;20180124174731

IQX

40399 NSX Issued Capital Other - Share Allotment on conversion of notes
Share Allotment on conversion of convertible notes
24-Jan-2018 5:47:23 PM;20180124174723

IQX

41999 NSX General Market Disclosure Other - IQX launches Equity Crowd Funding Platform
iQX Limited (NSX:iQX), part of The iQ Group Global, today announced Capital Labs, a business of its subsidiary company, is one of the first ASIC-authorised equity crowdfunding platforms in Australia. Capital Labs (capitallabs.com.au) is a first to market platform, dedicated to biotechnology and life science equity crowdfunding investments.
11-Jan-2018 2:00:38 PM;20180111140038

IQX

41999 NSX General Market Disclosure Other - Closure of Convertible Note Issue
Closure of Convertible Note Issue
22-Dec-2017 12:32:55 PM;20171222123255

IQX

40599 NSX Periodic Disclosure Other - Results of 2017 AGM
Results of 2017 AGM
27-Nov-2017 2:28:25 PM;20171127142825

IQX

40516 NSX Chairman's Address - 2017 Annual General Meeting Chairman's Address
2017 Annual General Meeting Chairman's Address
27-Nov-2017 10:21:49 AM;20171127102149

IQX

40910 NSX Notice of Annual General Meeting - Notice of 2017 Annual General Meeting
Notice of 2017 Annual General Meeting
27-Oct-2017 2:42:05 PM;20171027144205

IQX

Price Sensitive
40510 NSX Annual Report - 2017 Annual Report
2017 Annual Report
20-Oct-2017 2:42:05 PM;20171020144205

IQX

Price Sensitive
40530 NSX Preliminary/Final Statement - IQX Preliminary Final Report and Financials for 30 June 2017
IQX Preliminary Final Report and Financials for 30 June 2017
13-Sep-2017 8:11:21 PM;20170913201121

IQX

41999 NSX General Market Disclosure Other - Unconditional Registration for ESVCLP Fund
Unconditional Registration Approval for iQ Series 8 Life Science Fund (Global) ESVCLP LP
01-Sep-2017 12:17:52 PM;20170901121752

IQX

40024 NSX Nominated Adviser's Declaration - Nominated Adviser's Declaration
Nominated Adviser's Declaration
01-Sep-2017 10:20:36 AM;20170901102036

IQX

41999 NSX General Market Disclosure Other - Change of Company Auditor
Change of Company Auditor
31-Aug-2017 7:14:14 AM;20170831071414

IQX

41999 NSX General Market Disclosure Other - Extension of Private Placement
Extension of Private Placement
13-Apr-2017 7:21:12 PM;20170413192112

IQX

Price Sensitive
40540 NSX Half Yearly Report - 31 December 2016 Half Yearly Report
31 December 2016 Half Yearly Report
16-Mar-2017 4:50:00 PM;20170316165000

IQX

40320 NSX Issues to Public - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
10-Mar-2017 4:07:10 PM;20170310160710

IQX

40380 NSX Exercise of Options - Excercise of Options
Finalisation of Options
19-Dec-2016 3:20:26 PM;20161219152026

IQX

41999 NSX General Market Disclosure Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
18-Nov-2016 2:25:56 PM;20161118142556

IQX

40930 NSX Results of Meeting - Results of 2016 Annual General Meeting
Results of 2016 Annual General Meeting
18-Nov-2016 2:17:29 PM;20161118141729

IQX

40031 NSX Trading Halt Status - Removal of Trading Halt - Company to commence trading at 10.30am
Removal of Trading Halt - Company to commence trading at 10.30am
18-Nov-2016 10:14:16 AM;20161118101416

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Glucose Biosensor Systems (Greater China)
Glucose Biosensor Systems (Greater China) Proposed Listing
18-Nov-2016 10:03:49 AM;20161118100349

IQX

40030 NSX Trading Halt - iQX Requests Trading Halt
iQX Requests Trading Halt Pending Announcement
17-Nov-2016 9:22:23 AM;20161117092223

IQX

40380 NSX Exercise of Options - Excercise of Options In IQX
Exercise of Options Update
04-Nov-2016 4:03:28 PM;20161104160328

IQX

40910 NSX Notice of Annual General Meeting - IQX Notice of 2016 AGM
IQX Notice of 2016 AGM
17-Oct-2016 4:12:44 PM;20161017161244

IQX

40380 NSX Exercise of Options - Application for Quotation - Exercise of Options
Application for Quotation - Exercise of Options
28-Sep-2016 10:12:28 AM;20160928101228

IQX

Price Sensitive
40510 NSX Annual Report - 2016 Annual Report
2016 Annual Report
13-Sep-2016 4:59:17 PM;20160913165917

IQX

40380 NSX Exercise of Options - Exercise of Options
Summary of recent activity in company's options
07-Sep-2016 9:34:54 AM;20160907093454

IQX

40315 NSX Placement - Extension of Private Placement
Extension of Private Placement
01-Sep-2016 8:27:22 AM;20160901082722

IQX

40814 NSX Company Secretary Appointment/Resignation - Change of Company Secretary
Change of Company Secretary
22-Aug-2016 3:30:37 PM;20160822153037

IQX

40599 NSX Periodic Disclosure Other - Nominated Advisers Annual Statement to NSX
Nominated Advisers Annual Statement to NSX
21-Jul-2016 10:22:10 AM;20160721102210

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Acquisition of Novel Glucose Biosensor
IQN - IQX Subsidiary Acquires Novel Glucose Biosensor
29-Jun-2016 2:41:19 PM;20160629144119

IQX

40081 NSX Response to Query - Company Response to Price Query
Company Response to Price Query
18-Apr-2016 3:43:13 PM;20160418154313

IQX

40080 NSX Query - Price Query 14 April 2016
Price Query 14 April 2016
18-Apr-2016 3:41:55 PM;20160418154155

IQX

Price Sensitive
41999 NSX General Market Disclosure Other - Acquisition of oncology biologic compound
Acquisition of oncology biologic compound
05-Apr-2016 1:01:21 PM;20160405130121

IQX

41999 NSX General Market Disclosure Other - Quotation of Additional Securities
Quotation of Additional Securities
21-Mar-2016 4:30:24 PM;20160321163024

IQX

40380 NSX Exercise of Options - Exercise of Options
Exercise of Options
21-Mar-2016 4:29:50 PM;20160321162950

IQX

40550 NSX Half Yearly Report Audit Review - Financial Statements 31 December 2015
Financial Statements 31 December 2015
15-Mar-2016 3:18:35 PM;20160315151835

IQX

40365 NSX Extension of Offer - Extension of Private Placement to 31 August 2016
Extension of Private Placement
15-Mar-2016 3:16:23 PM;20160315151623

IQX

41999 NSX General Market Disclosure Other - Quotation of Additional Securities
Quotation of Additional Securities
18-Jan-2016 3:04:09 PM;20160118150409

IQX

40930 NSX Results of Meeting - Results of 2015 Annual General Meeting
Results of 2015 Annual General Meeting
17-Nov-2015 7:58:23 PM;20151117195823

IQX

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting
Notice of Annual General Meeting
28-Oct-2015 7:43:20 AM;20151028074320

IQX

Price Sensitive
40510 NSX Annual Report - iQX Limited 2015 Annual Report
iQX Limited 2015 Annual Report
11-Sep-2015 3:48:36 PM;20150911154836

IQX

41999 NSX General Market Disclosure Other - Closure of GXG Markets
Closure of GXG Markets
18-Aug-2015 3:41:54 PM;20150818154154

IQX

40599 NSX Periodic Disclosure Other - Nominated Advisers Annual Statement to NSX
Nominated Advisers Annual Statement to NSX
14-Aug-2015 2:44:20 PM;20150814144420

IQX

41999 NSX General Market Disclosure Other - Update - Nasdaq cross-listing
Update - Nasdaq cross-listing
14-Aug-2015 2:19:30 PM;20150814141930

IQX

40315 NSX Placement - Extension of Private Placement
Extension of Private Placement
24-Jul-2015 3:01:32 PM;20150724150132

IQX

40750 NSX Details of Share Registry - Change of Registry Address
Change of Registry Address
15-May-2015 4:41:05 PM;20150515164105

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Notice of Final Director's Interests
Notice of Final Director's Interests
30-Apr-2015 10:24:20 AM;20150430102420

IQX

40810 NSX Director Appointment/Resignation - Resignation of Mr Anthony Panoyan
Resignation of Mr Anthony Panoyan
30-Apr-2015 9:23:25 AM;20150430092325

IQX

Price Sensitive
40540 NSX Half Yearly Report - iQX Ltd Half Yearly Report
iQX Ltd - Half Yearly Report for the Period Ended 31st December 2014
13-Mar-2015 6:25:32 PM;20150313182532

IQX

41999 NSX General Market Disclosure Other - NASDAQ Cross-listing
NASDAQ Cross-listing
03-Mar-2015 12:13:04 PM;20150303121304

IQX

40320 NSX Issues to Public - Application for Quotation of Additional Shares - Release of Escrow
Application for Quotation of Additional Shares - Release of Escrow
15-Jan-2015 3:59:52 PM;20150115155952

IQX

40023 NSX Director's Declaration & Undertaking - Director's Declaration - George Syrmalis
Director's Declaration - George Syrmalis
14-Jan-2015 9:13:52 AM;20150114091352

IQX

Price Sensitive
40315 NSX Placement - Private Placement
Private Placement
18-Dec-2014 3:24:47 PM;20141218152447

IQX

41999 NSX General Market Disclosure Other - Development of Investment Fund
Development of Investment Fund
18-Dec-2014 3:23:58 PM;20141218152358

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Notice of Initial Director's Interests - George Syrmalis
Notice of Initial Director's Interests - George Syrmalis
02-Dec-2014 9:16:11 AM;20141202091611

IQX

40810 NSX Director Appointment/Resignation - Director Appointment - George Syrmalis
Director Appointment - George Syrmalis
02-Dec-2014 9:15:01 AM;20141202091501

IQX

40930 NSX Results of Meeting - Results of 2014 AGM
Results of 2014 AGM
02-Dec-2014 9:13:48 AM;20141202091348

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Director's Interests - A Dimos
Final Director's Interests - A Dimos
12-Nov-2014 9:50:07 AM;20141112095007

IQX

40910 NSX Notice of Annual General Meeting - 2014 IQX Notice of Annual General Meeting and Proxy
2014 IQX Notice of Annual General Meeting and Proxy
29-Oct-2014 9:48:00 PM;20141029214800

IQX

40810 NSX Director Appointment/Resignation - Director Resignation - Alex Dimos
Director Resignation - Alex Dimos
09-Oct-2014 1:12:16 PM;20141009131216

IQX

Price Sensitive
40510 NSX Annual Report - 2014 Annual Report
2014 Annual Report
12-Sep-2014 4:03:47 PM;20140912160347

IQX

40599 NSX Periodic Disclosure Other - Nominated Advisers Annual Statement to NSX
Nominated Advisers Annual Statement to NSX
18-Aug-2014 1:25:13 PM;20140818132513

IQX

40814 NSX Company Secretary Appointment/Resignation - Change of Company Secretary
Change of Company Secretary from Mr Spiro Sakiris to Mr Kelvin Boateng
24-Jul-2014 3:13:23 PM;20140724151323

IQX

41999 NSX General Market Disclosure Other - Granting of AFSL
Granting of Australian Financial Services Licence
11-Apr-2014 3:19:08 PM;20140411151908

IQX

Price Sensitive
40540 NSX Half Yearly Report - Half Yearly Financial Report
Financial Statements for the 6 months ended 31st December 2013
14-Mar-2014 2:16:20 PM;20140314141620

IQX

41999 NSX General Market Disclosure Other - IQX Ltd Admitted to GXG Exchange in Europe
IQX Ltd unanimously approved by the GXG Admissions Committee to commence trading on the Main Quote of GXG.
24-Dec-2013 11:47:27 AM;20131224114727

IQX

40110 NSX Becoming a Substantial Shareholder - Notice of Initial Substantial Shareholder - Adaptive Radiation Group
Notice of Initial Substantial Shareholder - Adaptive Radiation Group
13-Dec-2013 8:49:52 AM;20131213084952

IQX

40110 NSX Becoming a Substantial Shareholder - Notice of Initial Substantial Holder - IQX Limited
Notice of Initial Substantial Holder - IQX Limited
11-Dec-2013 4:29:12 PM;20131211162912

IQX

40110 NSX Becoming a Substantial Shareholder - Notice of Initial Substantial Holder - Life Science Group
Notice of Initial Substantial Holder - Life Science Group
11-Dec-2013 4:28:08 PM;20131211162808

IQX

40110 NSX Becoming a Substantial Shareholder - Notice of Initial Substantial Holder - Agparaskevi Group
Notice of Initial Substantial Holder - Agparaskevi Group
11-Dec-2013 4:27:29 PM;20131211162729

IQX

40110 NSX Becoming a Substantial Shareholder - Notice of Initial Substantial Holder - Ruminate Group
Notice of Initial Substantial Holder - Ruminate Group
11-Dec-2013 4:26:36 PM;20131211162636

IQX

40110 NSX Becoming a Substantial Shareholder - Notice of Initial Substantial Holder - Abiogenesis Group
Notice of Initial Substantial Holder - Abiogenesis Group
11-Dec-2013 4:25:55 PM;20131211162555

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - P Simpson
Initial Director's Interests - P Simpson
11-Dec-2013 4:24:24 PM;20131211162424

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - K Dimiariou
Initial Director's Interests - K Dimiariou
11-Dec-2013 4:23:54 PM;20131211162354

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - J Stratilas
Initial Director's Interests - J Stratilas
11-Dec-2013 4:23:25 PM;20131211162325

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - A Panoyan
Initial Director's Interests - A Panoyan
11-Dec-2013 4:22:50 PM;20131211162250

IQX

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - A Dimos
Initial Director's Interests - A Dimos
11-Dec-2013 4:22:20 PM;20131211162220

IQX

40520 NSX Top 20 Shareholders - Top 20 Shareholders
Top 20 Shareholders
10-Dec-2013 9:23:58 AM;20131210092358

IQX

40020 NSX Commencement of Official Quotation - Commencement of Quotation - Tuesday, 10th of December 2013
Commencement of Quotation - Tuesday, 10th of December 2013
09-Dec-2013 12:13:47 PM;20131209121347

IQX

40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - P Simpson
Director's Declaration & Undertaking - P Simpson
09-Dec-2013 12:13:04 PM;20131209121304

IQX

40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - K Dimiariou
Director's Declaration & Undertaking - K Dimiariou
09-Dec-2013 12:12:38 PM;20131209121238

IQX

40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - J Stratilas
Director's Declaration & Undertaking - J Stratilas
09-Dec-2013 12:12:14 PM;20131209121214

IQX

40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - A Panoyan
Director's Declaration & Undertaking - A Panoyan
09-Dec-2013 12:11:45 PM;20131209121145

IQX

40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - A Dimos
Director's Declaration & Undertaking - A Dimos
09-Dec-2013 12:10:09 PM;20131209121009

IQX

40099 NSX Official List Other - Issuers Undertaking
Issuers Undertaking
09-Dec-2013 12:08:52 PM;20131209120852

IQX

40024 NSX Nominated Adviser's Declaration - Nominated Adviser's Declaration
Nominated Adviser's Declaration
09-Dec-2013 12:08:03 PM;20131209120803

IQX

40510 NSX Annual Report - Annual Financial Statements - 30 June 2013
Annual Financial Statements - 30 June 2013
09-Dec-2013 12:00:48 PM;20131209120048

IQX

40022 NSX Articles of Association/Constitution - Constitution
Constitution
09-Dec-2013 11:59:30 AM;20131209115930

IQX

40350 NSX Prospectus - Prospectus
Prospectus
09-Dec-2013 11:58:48 AM;20131209115848

IQX

40099 NSX Official List Other - Listing Application
Listing Application
09-Dec-2013 11:56:56 AM;20131209115656